Lower prescription drug prices by holding Big Pharma accountable, cracking down on tactics that delay generic approvals, and speeding FDA approval of generics and new drugs.

Let’s lower prescription drug prices by holding Big Pharma accountable and cracking down on their schemes to slow generic drug approvals. Fix the FDA bureaucracy and accelerate approval of generics, and new drugs too.

Promise to reduce drug prices through anti-delay enforcement and faster FDA approvals.

ICYMI: Hawley Op-Ed: Missourians deserve quality health care at affordable prices |
primary · campaign_site · model gpt-5.4-mini

We also need to take a hard look at the bad trade deals that let foreign governments pay less for prescription drugs and shift research and development costs to Americans.

Promise to examine and oppose trade arrangements that push drug costs onto Americans.

ICYMI: Hawley Op-Ed: Missourians deserve quality health care at affordable prices |
primary · campaign_site · model gpt-5.4-mini

Hawley joined the Transparent Drug Pricing Act of 2019, saying the bill would lower prescription drug prices through greater price transparency and by ensuring Americans pay the same price as consumers in other parts of the world.

Shows Hawley taking concrete legislative action on drug prices early in his Senate career.

partial later_term A for effort

Senator Hawley Coauthors Bill to Lower Cost of Prescription Drugs
secondary · model gpt-5.4-mini · confidence 90%

Hawley unveiled the Fair Prescription Drug Prices for Americans Act and said his agenda would target the biggest abuses in the prescription drug market to reduce costs for patients.

Demonstrates continued legislative action on prescription drug pricing, but only at the proposal stage.

partial later_term A for effort

Hawley Puts Big Pharma on Notice, Unveils Two New Bills in Patients First Agenda to Cut Drug Costs
secondary · model gpt-5.4-mini · confidence 96%

Congress.gov shows Hawley introduced S.1218 and referred it to the Senate HELP Committee; the bill status is Introduced and the latest action is referral on 2023-04-19.

Official legislative record confirms the drug-price bill was introduced but not advanced to passage.

never later_term A for effort

S.1218 - Fair Prescription Drug Prices for Americans Act
secondary · model gpt-5.4-mini · confidence 99%

Hawley said Big Pharma uses anticompetitive patent thickets to drive up drug costs and prevent generic-drug manufacturers from entering the market, and he backed bipartisan legislation to break up those practices.

Matches the promise's generic-competition component and shows concrete legislative effort.

partial later_term A for effort

Hawley, Welch Introduce Legislation Targeting 'Patent Thickets' to Reduce Prescription Drug Prices
secondary · model gpt-5.4-mini · confidence 98%

Congress.gov records that S.2276, the ETHIC Act, was introduced and referred to the Senate Judiciary Committee, with no later legislative action shown on the history page.

Official record indicates the generic-competition bill was introduced but not enacted.

never later_term A for effort

S.2276 - ETHIC Act History
secondary · model gpt-5.4-mini · confidence 99%

Congress.gov lists S.1587 as introduced by Sen. Hawley and referred to the Senate HELP Committee on 2025-05-05; the tracker remains at Introduced.

Official legislative status shows the pricing bill remained a proposal rather than a delivered policy change.

never later_term A for effort

S.1587 - Fair Prescription Drug Prices for Americans Act
secondary · model gpt-5.4-mini · confidence 99%

On May 14, 2026, Hawley and Warren reintroduced the Patients Before Monopolies Act to prohibit PBMs from owning pharmacies and to curb prescription drug costs. The release says the bill is a step toward making healthcare more affordable, but it is still only a reintroduction, not enacted policy.

Recent official effort tied to lowering drug prices, but it remained a proposed bill rather than delivered policy.

partial later_term A for effort

Hawley, Warren Reintroduce Bipartisan Legislation to Limit PBMs, Put Patients First
secondary · model gpt-5.4-mini · confidence 96%

Congress.gov shows the ETHIC Act was introduced on July 15, 2025, to address patent thickets; the text page says it was read twice and referred to the Committee on the Judiciary. That is concrete legislative action on the generic-competition side of the promise, but not passage or implementation.

Direct official record of Hawley backing a patent-thicket bill, with referral to committee and no enacted result.

never later_term A for effort

S.2276 - ETHIC Act | Congress.gov | Library of Congress
secondary · model gpt-5.4-mini · confidence 99%